Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -103.99% is 64% below its 5-year average of -63.59%, near the high end of its 5-year range (-2175.22%–0.00%).
43.44% above its 12-month average of -183.86%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -320.76%.
OPERATING MARGIN
-103.99%
OPERATING MARGIN AVG TTM
-183.86%
OPERATING MARGIN AVG 3Y
-156.51%
OPERATING MARGIN AVG 5Y
-63.59%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+43.44%
CURRENT VS 3Y AVG
+33.56%
CURRENT VS 5Y AVG
-63.54%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 600 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Invivyd, Inc.
Market Cap
$245.35M
Operating Margin
-103.99%
TTM Avg
-183.86%
3Y Avg
-156.51%
5Y Avg
-63.59%
Market Cap
$243.81M
Operating Margin
N/A
TTM Avg
-7.18%
3Y Avg
-10.59%
5Y Avg
-10.29%
Market Cap
$243.81M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$241.04M
Operating Margin
-164525.50%
TTM Avg
-98218.45%
3Y Avg
-66780.63%
5Y Avg
-44520.42%
Market Cap
$250.48M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-2313.03%
5Y Avg
-2198.82%
Market Cap
$239.72M
Operating Margin
-1488.31%
TTM Avg
-4815.32%
3Y Avg
-6115.40%
5Y Avg
-4078.06%
Market Cap
$237.74M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$237.69M
Operating Margin
0.56%
TTM Avg
-0.74%
3Y Avg
-7.55%
5Y Avg
-6.74%
Market Cap
$253.80M
Operating Margin
-13.78%
TTM Avg
-1055.13%
3Y Avg
-2810.33%
5Y Avg
-1873.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $245.35M | -103.99% | -183.86% | -156.51% | -63.59% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | N/A | -7.18% | -10.59% | -10.29% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.81M | 0.00% | 0.00% | 0.00% | 0.00% |
| InflaRx N.V. (IFRX)vs › | $241.04M | -164525.50% | -98218.45% | -66780.63% | -44520.42% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | 0.00% | 0.00% | -2313.03% | -2198.82% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $239.72M | -1488.31% | -4815.32% | -6115.40% | -4078.06% |
| Galectin Therapeutics Inc. (GALT)vs › | $237.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| High Tide Inc. (HITI)vs › | $237.69M | 0.56% | -0.74% | -7.55% | -6.74% |
| Century Therapeutics, Inc. (IPSC)vs › | $253.80M | -13.78% | -1055.13% | -2810.33% | -1873.55% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $236.09M | 9.95% | -10.78% | -18.24% | -54.36% |
Gross Margin
91.3%
Operating Margin
-104.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -320.76% |
| 2026-03-31 | -313.85% |
| 2025-12-31 | -72.96% |
| 2025-09-30 | -83.96% |
| 2025-06-30 | -127.78% |
| 2025-03-31 | -149.70% |
| 2024-12-31 | -139.14% |
| 2024-09-30 | -670.01% |
| 2024-06-30 | -2175.22% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
